{
    "organizations": [],
    "uuid": "e4f0e3afbc6155340fd77d9cded3dddf95613322",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-amgen-announces-fda-advisory-commi/brief-amgen-announces-fda-advisory-committee-meeting-to-review-potential-new-use-of-blincyto-idUSFWN1Q41KO",
    "ord_in_thread": 0,
    "title": "BRIEF-Amgen Announces FDA Advisory Committee Meeting To Review Potential New Use Of Blincyto",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 14 (Reuters) - Amgen Inc:\n* AMGEN ANNOUNCES FDA ADVISORY COMMITTEE MEETING TO REVIEW POTENTIAL NEW USE OF BLINCYTOÂ® (BLINATUMOMAB)\n* AMGEN INC - FDA ADVISORY COMMITTEE MEETING TO REVIEW POTENTIAL NEW USE OF BLINCYTO AT A MEETING ON MARCH 7 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-15T05:07:00.000+02:00",
    "crawled": "2018-02-15T20:48:58.002+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "amgen",
        "inc",
        "amgen",
        "announces",
        "fda",
        "advisory",
        "committee",
        "meeting",
        "review",
        "potential",
        "new",
        "use",
        "blinatumomab",
        "amgen",
        "inc",
        "fda",
        "advisory",
        "committee",
        "meeting",
        "review",
        "potential",
        "new",
        "use",
        "blincyto",
        "meeting",
        "march",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}